Size matters: The ethical, legal, and social issues surrounding large-scale genetic biobank initiatives

Norsk Epidemiologi

Volumn 21, Issue 2, 2012, Pages 211-220

  Hoeyer, Klaus Lindgaard ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; BENEFICENCE; CONFIDENTIALITY; GENETIC DATABASE; HUMAN; HUMAN DIGNITY; INFORMATION DISSEMINATION; LEGAL ASPECT; MEDICAL INFORMATION SYSTEM; MEDICAL RESEARCH; PATIENT AUTONOMY; PATIENT INFORMATION; PROFESSIONAL COMPETENCE; PROFESSIONAL SECRECY; PROFESSIONALISM; PUBLIC-PRIVATE PARTNERSHIP; RESEARCH ETHICS; RESEARCH SUBJECT; SAMPLE SIZE; SOCIAL ASPECT;

EID: 84863009080     PISSN: 08032491     EISSN: None     Source Type: Journal    
DOI: 10.5324/nje.v21i2.1496     Document Type: Article

References (99)

1. Lawrence S. Beyond the Grave-The use and meaning of human body parts: A historical introduction. In: Weir RF, ed. Stored Tissue Samples. Ethical, Legal, and Public Policy Implications. Iowa: University of Iowa Press, 1998; 111-142.
2. Hoeyer K. After novelty: The mundane practices of ensuring a safe and stable supply of bone. Science as Culture 2010; 19: 123-150.
3. Ashburn T, Wilson S, Eisenstein B. Human tissue in the genomic era of medicine. Arch Intern Med 2000; 160: 3377-3384.
4. Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM. Trends in ethical and legal frameworks for the use of human biobanks. European Respiratory Journal 2007; 30: 373-382.
5. Hoeyer K. The ethics of research biobanking: A critical review of the literature. Biotechnology and Genetic Engineering Reviews 2008; 25: 429-452.
6. Burton PR, Hansell AL, Fortier I, et al. Size matters: just how big is BIG? International Journal of Epidemiology 2009; 38: 263-273.
7. Collins FS, Morgan M, Patrinos A. The Human Genome Project: Lessons from large-scale biology. Science 2003; 300: 286-290.
8. Galison P. Introduction. The many faces of Big Science. In: Galison P, ed. Big Science. The growth of largescale research. Stanford: Standford Unviersity Press, 1992; 1-20.
9. Park A. 10 Ideas Changing the World Right Now: Biobanks. TIME In partnership with CNN 2009.
10. Cambon-Thomsen A. The social and ethical issues of post-genomic human biobanks. Nature Review Genetics 2004; 5: 6-13.
11. Corrigan O, Tutton R. Biobanks and the Challenges of Governance, Legitimacy and Benefit. 2008.
12. Hoeyer K. Donors perceptions of consent to and feedback from biobank research: time to acknowledge diversity? Public Health Genomics 2010; 13: 345-352.
13. Winickoff DE, Winickoff RN. The charitable trust as a model for genomic biobanks. New England Journal of Medicine 2003; 349: 1180-1184.
14. Cambon-Thomsen A. Assessing the impact of biobanks. Nature Genetics 2003; 34: 25-26.
15. Abott A. Sweden sets ethical standards for use of genetic 'biobanks'. Nature 1999; 400: 3.
16. Nilsson A, Rose J. Sweden takes steps to protect tissue banks. Science 1999; 286: 894.
17. Hoeyer K, Tutton R. 'Ethics was here': Studying the language-games of ethics in the case of UK Biobank. Critical Public Health 2005; 15: 385-397.
18. Corrigan O. Empty ethics: The problem with informed consent. Sociology of Health and Illness 2003; 25: 768-792.
19. Hoeyer K. The role of ethics in commercial genetic research: Notes on the notion of commodification. Medical Anthropology 2005; 24: 45-70.
20. Metzler I. Über "Moralapostel" und "smooth operators": Die praxis der bioethik im feld eines Österreichischen biobankenprojekts. In: Griessler E, Rohracher H, eds. Genomforschung-Politik-Gesellschaft. Wiesbaden: VS Verlag, 2010.
21. Petersen A. Securing our genetic health: Engendering trust in UK Biobank. Sociology of Health and Illness 2005; 27: 271-292.
22. Árnason A, Simpson B. Refractions through culture: The new genomics in Iceland. Ethnos 2003; 68: 533-553.
23. Marks J. "We're going to tell these people who they really are": Science and relatedness. In: Franklin S, McKinnon S, eds. Relative Values. Reconfiguring Kinship Studies. Durham & London: Duke University Press, 2001: 355-383.
24. Reardon J. Race to the Finish: Identity and Governance in an Age of Genomics. New Jersey: Princeton University Press, 2005.
25. Braun B. Biopolitics and the molecularization of life. Cultural Geographies 2007; 14: 6-28.
26. Lupton D. Risk. 1st edn. London and New York: Routledge, 1999.
27. Novas C, Rose N. Genetic risk and the birth of the somatic individual. Economy and Society 2000; 29: 485-513.
28. Greene JA. Prescribing by Numbers: Drugs and the Definition of Disease. Baltimore: Johns Hopkins University Press, 2007.
29. Traulsen JM, Björnsdóttir I, Almarsdóttir AB. 'I'm happy if I can help'. Public views on future medicines and gene-based therapy in Iceland. Community Genetics 2008; 11: 2-10.
30. Finkler K, Skrzynia C, Evans JP. The new genetics and its consequences for family, kinship, medicine and medical genetics. Social Science and Medicine 2003; 57: 403-412.
31. Hoeyer K. Conflicting notions of personhood in genetic research. Anthropology Today 2002; 18: 9-13.
32. Rabinow P. Severing the ties: Fragmetation and dignity in late modernity. Knowledge and Society: The Anthropology of Science and Technology 1992; 9: 169-187.
33. Bynum CW. Fragmentation and Redemption: Essays on Gender and the Human Body in Medieval Religion. New York: Zone Books, 1991.
34. Bynum CW. The Resurrection of the Body in Western Christianity, 200-1336. New York: Columbia University Press, 1995.
35. Hird MJ. The Origins of Sociable Life: Evolution After Science Studies. Hampshire: Palgrave Macmillan, 2009.
36. Basu S, Martin SW, Phillips RM, Puri R. Obtaining archived pathological material for biomedical research. Lancet 2003; 361: 1394.
37. Clayton EW. Informed consent and biobanks. Journal of Law, Medicine & Ethics 2005; 33: 15-21.
38. Elger B, Biller-Andorno N, Mauron A, Capron AM. Ethical Issues in Governing Biobanks: Global Perspectives. Aldershot, England: Ashgate, 2008.
39. Bauer K, Taub S, Parsi K. Ethical issues in tissue banking for research: a brief review of existing organizational policies. Theoretical Medicine 2004; 25: 113-142.
40. Maschke KJ, Murray TH. Ethical issues in tissue banking for research: the prospects and pitfalss of setting international standards. Theoretical Medicine 2004; 25: 143-155.
41. de Faria P. Ownership rights in research biobanks: Do we need a new kind of 'biological property'? In: Solbakk JH, Holm S, Hofmann B, eds. The Ethics of Research Biobanking. Springer, 2009.
42. Bovenberg JA. Property Rights in Blood, Genes and Data: Naturally Yours? Leiden: Martinus Nijhoff Publishers, 2006.
43. Laurie G. Genetic Privacy. A Challenge to Medico-Legal Norms. Cambridge: Cambridge University Press, 2002.
44. Lewis G. Tissue collection and the pharmaceutical industry: investigating corporate biobanks. In: Tutton R, Corrigan O, eds. Genetic Databases. Socio-ethical issues in the collection and use of DNA. London: Routledge, 2004: 181-202.
45. Anderlik MR. Commercial biobanks and genetic research: Ethical and legal issues. American Journal of Pharmacogenomics 2003; 3: 203-215.
46. Barbour V. Who's looking at your DNA? Lancet 2002; 360: 1850.
47. Heller MA, Eisenberg RS. Can patents deter innovation? The anticommons in biomedical research. Science 1998; 280: 698-701.
48. Eisenberg RS. Noncompliance, nonenforcement, nonproblem? Rethinking the anticommons in biomedical research. Houston Law Review 2008; 45: 1059-1099.
49. Clark BJ, Baust JM, Stacey G. How much will biobanking industry come to rely on private companies? Biopreservation and Biobanking 2010; 8: 179-180.
50. Ouellette LL. Access to bio-knowledge: From gene patents to biomedical materials. Standford Technology Law Review 2010; 1.
51. Gibbons SM, Kaye J, Smart A, Heeney C, Parker M. Governing genetic databases: Challenges facing research regulation and practice. Journal of Law and Society 2007; 34: 163-189.
52. Kaye J. Regulating human genetic databases in Europe. In: Häyry M, Chadwick R, Árnason V, Árnason G, eds. The Ethics and Governance of Human Genetic Databases. Cambridge: Cambridge University Press, 2007: 91-95.
53. Kaye J. Abandoning informed consent: the case of genetic research in population collections. In: Tutton R, Corrigan O, eds. Genetic Databases. Socio-ethical issues in the collection and use of DNA. London: Routledge; 2004: 117-138.
54. Calabresi G. An introduction to legal thought: four approaches to law and to the allocation of body parts. Standford Law Review 2003; 55: 2113-2151.
55. Hartlev M. Sundhedsvidenskabelige informationsbanker. Biobanker. Den Retlige Regulering af Biobanker. Love og Rekommandationer. Copenhagen: Lægeforeningens Forlag, 1996.
56. Diest P.V, Savulescu J. For and against: No consent should be needed for using leftover body material for scientific purposes. BMJ 2002; 325: 648-651.
57. Greely HT. The uneasy ethical and legal underpinnings of large-scale genomic biobanks. Annual Reviews of Genomics and Human Genetics 2007; 8: 343-364.
58. Arnason V. Coding and consent: Moral challenges of the database project in Iceland. Bioethics 2004; 18: 27-49.
59. Nõmper A. Open Consent-A New Form of Informed Consent for Population Genetic Databases. Tartu University, 2005.
60. Wendler D. One time general consent for research on biological samples. British Medical Journal 2006; 332: 544-547.
61. Weldon S. 'Public consent' or 'scientific citizenship'? What counts as public participation in population-based DNA collections? In: Tutton R, Corrigan O, eds. Genetic Databases: Socio-Ethical Issues in the Collection and Use of DNA. London: Routledge, 2004: 161-180.
62. Kristinsson S, Árnason V. Informed consent and human genetic database research. In: Häyry M, Chadwick R, Árnason V, Árnason G, eds. The Ethics and Governance of Human Genetic Databases. Cambridge: Cambridge University Press, 2007: 199-216.
63. Knoppers B, Laberge C. Research and stored tissue. Persons as sources, samples as persons? JAMA 1995; 274: 1806-1807.
64. Häyry M, Takala T. American principles, European values and the mezzanine rules of ethical genetic databanking. In: Häyry M, Chadwick R, Árnason V, Árnason G, eds. The Ethics and Governance of Human Genetic Databases. Cambridge: Cambridge University Press, 2007: 14-36.
65. Eriksson S, Helgeson G. Potential harms, anonymization, and the right to withdraw consent to biobank research. European Journal of Human Genetics 2005; 13: 1071-1076.
66. Corrigan OP, Williams-Jones B. Pharmacogenetics: the bioethical problem of DNA investment banking. Studies in History and Philosophy of Biological and Biomedical Sciences 2006; 37: 550-565.
67. Chadwick R, Berg K. Solidarity and equity: new ethical frameworks for genetic databases. Science in Society 2001; 2: 318-321.
68. Whong-Barr M. Informed consent and the shaping of British and US population-based genetic research. In: Guston D, Sarawitz D, eds. Shaping Science & Technology Policy: The New Generation of Research. Madison: University of Wisconsin Press, 2006: 291-311.
69. Anderlik MR, Rothstein MA. Privacy and confidentiality of genetic information: What rules for the new science? Annual Reviews of Genomics and Human Genetics 2001; 2: 401-433.
70. Taylor M, Townend D. Issues in protecting privacy in medical research using genetic information and biobanking: The PRIVILEGED Project. Medical Law International 2010; 10: 253-268.
71. Ursin LØ. Privacy and property in the biobank context. HEC Forum 2010; 22: 211-224.
72. Knoppers BM, Joly Y, Simard J, Durocher F. The emergence of an ethical duty to disclose genetic research results: international perspectives. European Journal of Human Genetics 2006; 14: 1170-1178.
73. Brey P. Human enhancement and personal identity. In: Olsen JKB, Selinger E, Riis S, eds. New Waves in Philosophy of Technology. Basingstoke, Hampshire: Palgrave Macmillan, 2008: 169-185.
74. Elliott C. Better than well: American medicine meets the American dream. New York: Norton & Company, 2003.
75. Hogle LF. Enhancement technologies and the body. Annual Review of Anthropology 2005; 34: 695-716.
76. Wilson S, Chadwick R. Pursuing equality: questions of social justice and population genomics. In: Häyry M, Chadwick R, Árnason V, Árnason G, eds. The Ethics and Governance of Human Genetic Databases. Cambridge: Cambridge University Press, 2007: 150-157.
77. Simm K. Benefit-sharing: An inquiry regarding the meaning and limits of the concept in human genetic research. Genomics, Society and Policy 2005; 1: 29-40.
78. Wolk S. Biobanksrätt. Lund: Studentlitteratur, 2003.
79. Fernandez CV, Santor D, Weijer C, et al. The return of research results to participants: Pilot questionnaire of adolescents and parents of children with cancer. Pediatric Blood and Cancer 2007; 48: 441-446.
80. Fernandez CV, Skedgel C, Weijer C. Considerations and costs of disclosing study findings to research participants. CMAJ 2004; 170: 1417-1419.
81. Fernandez CV, Kodish E, Weijer C. Informing study participants of research results: An ethical imperative. IRB: Ethics & Human Research 2003; 25: 12-19.
82. Ravitsky V, Wilfond BS. Disclosing individual genetic results to research participants. American Journal of Bioethics 2006; 6: 8-17.
83. Renegar G, Webster CJ, Stuerzbecher S, et al. Returning genetic research results to individuals: points-toconsider. Bioethics 2006; 20: 24-36.
84. Widdows H, Cordell S. Why communities and their goods matter: Illustrated with the example of biobanks. Public Health Ethics 2011; 4: 14-25.
85. Hart JT. The inverse care law. Lancet 1971; 1: 405-412.
86. Evans JP, Meslin EM, Marteau TM, Caulfield T. Deflating the genomic bubble. Science 2011; 331: 861-862.
87. Chen Z, et al. Cohort Profile: The Kadoorie Study of Chronic Disease in China (KSCDC). International Journal of Epidemiology 2005; 34: 1243-1249.
88. Sirugo G, et al. A national DNA bank in The Gambia, West Africa, and genomic research in developing countries. Nature Genetics 2004; 36: 785-786.
89. Tapia-Conyer R, et al. Cohort Profile: The Mexico City Prospective Study. International Journal of Epidemiology 2006; 35: 243-249.
90. Kattel R. Genetic databases and governance. In: Häyry M, Chadwick R, Árnason V, Árnason G, eds. The Ethics and Governance of Human Genetic Databases. Cambridge: Cambridge University Press, 2007: 236-245.
91. Cunningham H. Colonial encounters in postcolonial contexts. Critique of Anthropology 1998; 18: 205-233.
92. Thacker E. The global genome. Biotechnology, politics, and culture. Cambridge, Massachusetts: MIT Press, 2005.
93. Gaskell G, Gottweis H. Biobanks need publicity. Nature 2011; 471: 159-160.
94. Gottweis H, Zatloukal K. Biobank governance: Trends and perspectives. Pathobiology 2007; 74: 206-211.
95. Petersen A. Biobanks' "engagements": engendering trust or engineering consent? Genomics, Society and Policy 2007; 3: 31-43.
96. European commission. Europeans and Biotechnology in 2010. Winds of change? Brussels, 2010.
97. O'Neill O. Autonomy and Trust in Bioethics. Cambridge: Cambridge University Press, 2002.
98. Secko DM, Preto N, Niemeyer S, Burgess MM. Informed consent in biobank research: A deliberative approach to the debate. Social Science & Medicine 2009; 68: 781-789.
99. Gibbons SM. From principles to practice: Implementing genetic database governance. Medical Law International 2008; 9: 101-109.